Purchases and Sales Made in Q1 2023 in Atara Biotherapeutics, Inc. (ATRA)
This table provides information about the institutional ownership of Atara Biotherapeutics, Inc. (ATRA) during Q1 2023. The information is specifically focused on institutions that hold shares of Atara Biotherapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2023
Q1 2023
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-95.2K- 30.64% |
$267K - $520K
|
216K
$3.05M
|
|
May 15, 2023
Q1 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-103K- 53.79% |
$288K - $562K
|
88.4K
$1.25M
|
|
May 11, 2023
Q1 2023
|
Citigroup Inc
|
SELL
|
- |
-114K- 11.14% |
$320K - $624K
|
911K
$12.9M
|
|
May 15, 2023
Q1 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-130K- 87.66% |
$363K - $708K
|
18.3K
$259K
|
|
May 15, 2023
Q1 2023
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-308K- 32.02% |
$864K - $1.68M
|
655K
$9.27M
|
|
May 15, 2023
Q1 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-356K- 4.93% |
$996K - $1.94M
|
6.86M
$97.1M
|
|
May 15, 2023
Q1 2023
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-631K- 10.1% |
$1.77M - $3.44M
|
5.61M
$79.5M
|